Progress in Haemophilus type b polysaccharide vaccine use in the United States.
Cochi
S L
SL
Division of Immunization, Centers for Disease Control, Atlanta.
O'Mara
D
D
Preblud
S R
SR
D016667:Bacterial Capsules; D001428:Bacterial Vaccines; D002675:Child, Preschool; D003365:Costs and Cost Analysis; D006192:Haemophilus Infections / Q000453:epidemiology / Q000517:prevention & control*; D018073:Haemophilus Vaccines; D006193:Haemophilus influenzae / Q000276:immunology; D006801:Humans; D007114:Immunization / Q000191:economics; D007223:Infant; D011135:Polysaccharides, Bacterial; D014481:United States
D001428:Bacterial Vaccines; D018073:Haemophilus Vaccines; C044237:Haemophilus influenzae type b polysaccharide vaccine; D011135:Polysaccharides, Bacterial